tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Similar Stocks

Compare
1,082 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$36.30
$3.51B
-26.40%
12 Buy
1 Hold
0 Sell
Strong Buy
Travere Therapeutics
$34.51
$3.13B
84.05%
10 Buy
2 Hold
0 Sell
Strong Buy
Xenon
$43.52
$3.48B
3.50%
14 Buy
0 Hold
0 Sell
Strong Buy
Disc Medicine
$91.72
$3.48B
41.85%
13 Buy
0 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$79.55
$3.47B
57.03%
6 Buy
1 Hold
0 Sell
Strong Buy
Mineralys Therapeutics, Inc.
$36.73
$3.05B
179.53%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RARE
Ultragenyx Pharmaceutical
36.30
-12.56
-25.71%
TVTX
Travere Therapeutics
34.51
15.83
84.74%
XENE
Xenon
43.52
0.55
1.28%
IRON
Disc Medicine
91.72
25.79
39.12%
TARS
Tarsus Pharmaceuticals
79.55
27.41
52.57%
MLYS
Mineralys Therapeutics, Inc.
36.73
23.78
183.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts